Harmonizing the classification of age-related macular degeneration in the three-continent AMD consortium

Ophthalmic Epidemiology

Volumn 21, Issue 1, 2014, Pages 14-23

  Klein, Ronald ^a   Meuer, Stacy M ^a   Myers, Chelsea E ^a   Buitendijk, Gabriëlle H S ^b   Rochtchina, Elena ^c   Choudhury, Farzana ^e   De Jong, Paulus T V M ^f,g,h   McKean Cowdin, Roberta ^e   Iyengar, Sudha K ⁱ   Gao, Xiaoyi ^e   Lee, Kristine E ^a   Vingerling, Johannes R ^b   Mitchell, Paul ^c   Klaver, Caroline C W ^b   Wang, Jie Jin ^c,d   Klein, Barbara E K ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age related macular degeneration; Classification; Epidemiology; Grading; Population based studies

Indexed keywords

ADULT; AGE RELATED MACULAR DEGENERATION SEVERITY SCALE; AGED; ALGORITHM; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL IMAGING; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUSEN; EYE PHOTOGRAPHY; FUNDUS CAMERA; GEOGRAPHIC ATROPHY; GROUPS BY AGE AND SEX; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION;

AGED; AGED, 80 AND OVER; AUSTRALIA; COHORT STUDIES; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84893413783     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.3109/09286586.2013.867512     Document Type: Article

References (43)

1. Priya RR, Chew EY, Swaroop A. Genetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management. Ophthalmology 2012;119(12):2526-2536.
2. Sivakumaran TA, Igo Jr. RP, Kidd JM, et al. A 32 kb critical region excluding Y402H in CFH mediates risk for age-related macular degeneration. PLoS One 2011;6(10):e25598.
3. Chen Y, Zeng J, Zhao C, et al. Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. Arch Ophthalmol 2011; 129(3):344-351.
4. McKay GJ, Patterson CC, Chakravarthy U, et al. Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat 2011; 32(12):1407-1416.
5. Fan Q, Barathi VA, Cheng CY, et al. Genetic variants on chromosome 1q41 influence ocular axial length and high myopia. PLoS Genet 2012;8(6):e1002753.
6. Fritsche LG, Chen W, Schu M, et al. Seven new loci associated with age-related macular degeneration. Nat Genet 2013;45(4):433-432.
7. Sim X, Jensen RA, Ikram MK, et al. Genetic loci for retinal arteriolar microcirculation. PLoS One 2013;8(6):e65804.
8. Verhoeven VJ, Hysi PG, Wojciechowski R, et al. Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet 2013;45(3):314-318.
9. de Bakker PI, Neale BM, Daly MJ. Meta-analysis of genome-wide association studies. Cold Spring Harb Protoc 2010;2010(6):pdb.top81.
10. Cornelis MC, Agrawal A, Cole JW, et al. The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet Epidemiol 2010;34(4):364-372.
11. Tomany SC, Wang JJ, van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004;111(7):1280-1287.
12. van Leeuwen R, Tomany SC, Wang JJ, et al. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. Ophthalmology 2004;111(6):1169-1175.
13. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001;108(4):697-704.
14. Linton KL, Klein BE, Klein R. The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye Study. Am J Epidemiol 1991;134(12):1438-1446.
15. Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: visual acuity. Ophthalmology 1991; 98(8):1310-1315.
16. Klein R, Klein BE, Lee KE. Changes in visual acuity in a population. The Beaver Dam Eye Study. Ophthalmology 1996;103(8):1169-1178.
17. Klein R, Klein BE, Lee KE, et al. Changes in visual acuity in a population over a 10-year period: the Beaver Dam Eye Study. Ophthalmology 2001;108(10):1757-1766.
18. Klein R, Klein BE, Lee KE, et al. Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study. Am J Ophthalmol 2006;142(4):539-549.
19. Klein R, Lee KE, Gangnon RE, Klein BE. Incidence of visual impairment over a 20-year period: the Beaver Dam Eye Study. Ophthalmology 2013;120(6):1210-1219.
20. Klein R, Davis MD, Magli YL, et al. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology 1991; 98(7):1128-1134.
21. Klein R, Davis MD, Magli YL, et al. The Wisconsin Age-Related Maculopathy Grading System. Springfield, VA: National Technical Information Service; 1991 Jul. Report No.: PB91-184267.
22. Klein R, Klein BE. The Beaver Dam Eye Study. Manual of Operations, Revised. Springfield, VA: National Technical Information Service; 1991. Report No.: PB91-149823.
23. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99(6):933-943.
24. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 1997;104(1):7-21.
25. Klein R, Klein BE, Tomany SC, et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 2002;109(10):1767-1779.
26. Klein R, Klein BE, Knudtson MD, et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007; 114(2):253-262.
27. Klein R, Myers CE, Meuer SM, et al. Risk alleles in CFH and ARMS2 and the long term natural history of age-related macular degeneration. The Beaver Dam Eye Study. JAMA Ophthalmol 2013;131(3):383-392.
28. Klein R, Klein BE, Moss SE. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. Am J Epidemiol 1998;147(2):103-110.
29. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995;102(10):1450-1460.
30. Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology 2002;109(6):1092-1097.
31. Wang JJ, Rochtchina E, Lee AJ, et al. Ten-year incidence and progression of age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 2007;114(1):92-98.
32. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculo-pathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39(5):367-374.
33. Varma R, Paz SH, Azen SP, et al. The Los Angeles Latino Eye Study: design, methods, and baseline data. Ophthalmology 2004;111(6):1121-1131.
34. Varma R, Fraser-Bell S, Tan S, et al. Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study. Ophthalmology 2004; 111(7):1288-1297.
35. McKean-Cowdin R, Varma R, Hays RD, et al. Longitudinal changes in visual acuity and health-related quality of life: the Los Angeles Latino Eye study. Ophthalmology 2010; 117(10):1900-1907, 1907.e1.
36. Davis MD, Gangnon RE, Lee LY, et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 2005;123(11):1484-1498.
37. Hofman A, van Duijn CM, Franco OH, et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol 2011;26(8):657-686.
38. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995;102(2):205-210.
39. Klaver CC, Assink JJ, Van LR, et al. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 2001; 42(10):2237-2241.
40. van Leeuwen R, Klaver CC, Vingerling JR, et al. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 2003;121(4):519-526.
41. Fleiss JL, Cohen J. The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educ Psychol Meas 2012;33:613-619.
42. Chew EY, Kim J, Sperduto RD, et al. Evaluation of the age-related eye disease study clinical lens grading system AREDS report No. 31. Ophthalmology 2010;117(11): 2112-2119.
43. Milton RC, Ganley JP, Lynk RH. Variability in grading diabetic retinopathy from stereo fundus photographs: comparison of physician and lay readers. Br J Ophthalmol 1977;61(3):192-201.